Lowering levels of bad cholesterol could cut your risk of dementia by 26%, new study claims
Experts said more studies are needed to test whether higher levels of bad cholesterol actually cause dementia, or if it is ...
Healio7d
Lepodisiran lowers Lp(a) substantially with infrequent administration
CHICAGO — Lepodisiran, a small interfering RNA agent, lowered lipoprotein(a) levels at 180 days, with a reduction of more ...
Medscape1mon
Understanding the Essentials of Blood Lipid Metabolism
Each lipoprotein class (chylomicrons ... interactions between HDL apolipoproteins and enzyme activity, is highly complex and poorly understood. HDL particles are synthesized and catabolized ...
The New England Journal of Medicine8d
Lepodisiran — A Long-Duration Small Interfering RNA Targeting Lipoprotein(a)
Elevated lipoprotein(a) concentrations are associated with atherosclerotic cardiovascular disease. The safety and efficacy of lepodisiran, an extended-duration, small interfering RNA targeting ...